Fast-food chain operator Yoshinoya Co. has successfully tested a drone service to deliver its “gyudon” beef-on-rice dishes to customers.
In a flight demonstration, Yoshinoya staff cooked up gyudon dishes for four people, which delivery service operator Demae-can Co. placed on a box that keeps them warm and loaded onto a drone.
It took 10 minutes for the drone to arrived on the roof of a hospital some five kilometers away.
The gyudon dishes were handed out to hospital personnel.
The drone used in the test can deliver up to five kilograms.
Demae-can president Hideo Fujii said that the company is exploring ways of delivering via drones, such as for a substantial amount of food.
The country's Civil Aeronautics Law had to be revised, which may be done as early as fiscal 2022, to allow drones to fly beyond the operators' line of sight and even above urban areas and locations where people live.


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Instagram Outage Disrupts Thousands of U.S. Users
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Thailand Inflation Remains Negative for 10th Straight Month in January
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



